Ten most commonly asked questions about management of hypertension.
Chockalingam
A
A
Disease Prevention Division, Systems for Health Directorate, Health Canada, Ottawa, Ontario, Canada.
Fodor
J G
JG
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000628:therapy*
D000317:Adrenergic alpha-Antagonists; D002121:Calcium Channel Blockers; D004232:Diuretics